tumor necrosis factor
[대역어] 종양괴사인자
[용어속성] Term
[용어속성] Term
Efficacy and safety of upadacitinib in patients with ankylosing spondylitis refractory to biologic therapy: 1-year results from the open-label extension of a phase III study
article
[키워드] ankylosing spondylitis
biologic
Inadequate response
Janus kinase inhibitor
Open-label extension
refractory
tumor necrosis factor
Upadacitinib
[DOI] 10.1186/s13075-023-03128-1 PMC 바로가기 [Article Type] article
[DOI] 10.1186/s13075-023-03128-1 PMC 바로가기 [Article Type] article
The effect of ACE2 receptor, IFN-γ, and TNF-α polymorphisms on the severity and prognosis of the disease in SARS-CoV-2 infection
Original Article
[키워드] angiotensin converting enzyme
Coronavirus disease 2019
disease severity
gene variations
interferon
tumor necrosis factor
[DOI] 10.1177/10815589231158379 PMC 바로가기 [Article Type] Original Article
[DOI] 10.1177/10815589231158379 PMC 바로가기 [Article Type] Original Article
Epipharyngeal Abrasive Therapy (EAT) Reduces the mRNA Expression of Major Proinflammatory Cytokine IL-6 in Chronic Epipharyngitis
Epipharyngeal Abrasive Therapy(EAT)는 만성 인두염에서 주요 전염증성 사이토카인 IL-6의 mRNA 발현을 감소시킵니다
Article
[키워드] Abrasive
addition
aggregation
Alpha
analyzed
anti-inflammatory effect
Cell
chronic
chronic fatigue syndrome
chronic inflammation
contribute
cough
COVID
cytokine
cytokine network
Cytokines
Diseases
effective
epipharyngeal abrasive therapy (EAT)
epipharyngitis
epipharynx
expression
expression pattern
fatigue
fatigue syndrome
Hypothesis
IgA
IgA nephropathy
IL-6
IL-6 expression
IMPROVE
In situ hybridization
induce
Inflammatory cytokine
Inflammatory cytokines
Inflammatory diseases
interleukin
interleukin 6
interleukin 6 (IL-6)
intractable
involved
Japan
Local
Long
Long COVID
Major
mechanisms
mRNA
myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)
nasal
Nasal cavity
Necrosis
nephropathy
Patient
postnasal drip
Proinflammatory cytokine
reduced
reported
responsible
Sedation
significantly lower
subject
suggested
suppressed
suppression
Symptom
syndrome
systemic inflammatory disease
systemic inflammatory diseases
systemic symptoms
therapy
TNFα
treated
Treatment
Tumor
tumor necrosis
tumor necrosis factor
tumor necrosis factor alpha
tumor necrosis factor alpha (TNFα).
upper respiratory tract
[DOI] 10.3390/ijms23169205 PMC 바로가기 [Article Type] Article
[DOI] 10.3390/ijms23169205 PMC 바로가기 [Article Type] Article
Tissue repair strategies: What we have learned from COVID-19 in the application of MSCs therapy
Review article
[키워드] ACE2angiotensin converting enzyme 2
acute lung injury
acute respiratory distress syndrome
adverse outcome
ALIacute lung injury
alveolar type 2 cells
angiotensin converting enzyme 2
ARDSacute respiratory distress syndrome
AstraZeneca
AT2salveolar type 2 cells
ataxia telangiectasia and Rad3-related
ATRataxia telangiectasia and Rad3-related
BDNFbrain derived neurotrophic factor
brain derived neurotrophic factor
BRDbromodomain protein
bromodomain protein
C-reactive protein
CCNG1Cyclin G1
CD147cluster of differentiation 147
Cell
Clinical finding
cluster of differentiation 147
confirmed case
Coronavirus disease 2019
COVID-19
COVID-19 pandemic
COVID-19 patients
COVID-19coronavirus disease 2019
CRPC-reactive protein
Cyclin G1
Cytokine storm
DRP1dynamin-related protein 1
dynamin-related protein 1
ECMOextracorporeal membrane oxygenation
effective
EGFepidermal growth factor
Emergency use authorization
epidermal growth factor
EUAemergency use authorization
EVsextracellular vesicles
example
exhibited
Extracellular vesicles
extracorporeal membrane oxygenation
FGFfibroblast growth factor
fibroblast growth factor
galanin and gmap prepropeptide
GALgalanin and gmap prepropeptide
GM-CSFgranulocyte macrophage-colony stimulating factor
granulocyte macrophage-colony stimulating factor
HBVHepatitis B virus
Heme oxygenase-1
Hepatitis B virus
hepatocyte growth factor
hESCshuman embryonic stem cells
HGFhepatocyte growth factor
hiPSCshuman induced PSCs
HIVhuman immunodeficiency virus
HO-1heme oxygenase-1
hPSC-CMshPSC-derived cardiomyocytes
hPSC-derived cardiomyocytes
hPSCshuman pluripotent stem cells
human embryonic stem cells
Human immunodeficiency virus
human induced PSCs
human pluripotent stem cells
Hyperinflammatory syndrome
IFN-βinterferon-β
IFN-γinterferon-γ
IFN-λinterferon-λ
IGF1Rinsulin like growth factor 1 receptor
Infection
insulin like growth factor 1 receptor
Intensive
Interferon-β
interferon-γ
interferon-λ
keratinocyte growth factor-2
KGF2keratinocyte growth factor-2
leukemia inhibitory factor
LIFleukemia inhibitory factor
management
MECP2methyl-CpG binding protein 2
Mesenchymal stem cells
methyl-CpG binding protein 2
Microvesicles
Moderna
Mortality
MSCs
MSCs therapy
MSCsmesenchymal stem cells
MVsmicrovesicles
National Institutes of Health
nerve growth factor
NGFnerve growth factor
NIHNational Institutes of Health
nitric oxide associated 1
NLR family pyrin domain containing 3
NLRP3NLR family pyrin domain containing 3
NOA1nitric oxide associated 1
organ damage
organ injury
P4HA1prolyl 4-hydroxylase subunit alpha 1
PDGFplatelet-derived growth factor
Pfizer
PGE2prostaglandin E2
phosphatase and tensin homolog
platelet-derived growth factor
Preclinical
Preferred reporting items for systematic reviews and meta-analyses
PRISMAPreferred reporting items for systematic reviews and meta-analyses
proinflammatory
prolyl 4-hydroxylase subunit alpha 1
prostaglandin E2
PTENphosphatase and tensin homolog
Pulmonary infection
Randomized controlled trial
RCTrandomized controlled trial
S-proteinspike protein
SARS-CoV-2severe acute respiratory syndrome coronavirus 2
SEMA3Asemaphorin 3 A
semaphorin 3 A
severe acute respiratory syndrome coronavirus 2
sialyl Lewis X
signal transducer and activator of transcription 3
SLeXsialyl Lewis X
Spike protein
spread of COVID-19
STAT3signal transducer and activator of transcription 3
stem cell
TGF-β1transforming growth factor β1
TGFBR1transforming growth factor β receptor I
Therapies
therapy
tissue regeneration
TLR4toll-like receptors 4
TMPRSS2transmembrane protease serine protease 2
TNFTumor Necrosis Factor
toll-like receptors 4
transforming growth factor β receptor I
transforming growth factor β1
transmembrane protease serine protease 2
tumor necrosis factor
utility
Vaccine
Vaccines
vascular cell adhesion molecule
vascular endothelial growth factor
VCAMvascular cell adhesion molecule
VEGFvascular endothelial growth factor
[DOI] 10.1016/j.phrs.2022.106334 [Article Type] Review article
[DOI] 10.1016/j.phrs.2022.106334 [Article Type] Review article
Role of therapeutic plasma exchange in the management of COVID-19-induced cytokine storm syndrome
Review article
Published on
Journal: Transfusion and apheresis science : official journ [Category] SARS, 바이오마커, 임상, 치료제,
Journal: Transfusion and apheresis science : official journ [Category] SARS, 바이오마커, 임상, 치료제,
[키워드] member 13
a disintegrin and metalloproteinase with a thrombospondin type 1 motif
acute respiratory syndrome
ADAMTS-13a disintegrin and metalloproteinase with a thrombospondin type 1 motif
American Society for Apheresis
approach
ARDSacute respiratory syndrome
article
ASFAAmerican Society for Apheresis
available data
benefit
C-reactive protein
Case series
Case-control
CCPCOVID-19 convalescent plasma
Clinical outcome
Coagulopathy
conducted
Controlled clinical trial
coronavirus disease
Coronavirus disease 2019
COVID-19
COVID-19 convalescent plasma
COVID-19coronavirus disease 2019
criteria
Critically ill patient
CRPC-reactive protein
CSS
CSScytokine storm syndrome
Cytokine storm syndrome
Cytokines
D-dimer
Effects
Evidence
excessive immune response
feasibility
ferritin
FFPfresh frozen plasma
fibrinogen level
fresh frozen plasma
hypercoagulable
Hyperinflammatory
ICUIntensive Care Unit
identify
IFNinterferon
ILInterleukin
immunomodulatory effect
improvement
Inflammatory factor
intensive care unit
interferon
interleukin
interleukin-6
Intervention
Length of stay
LOSlength of stay
Lymphocyte count
macrophage activation syndrome
management
MASmacrophage activation syndrome
MODSmultiple organ dysfunction syndrome
Mortality
multiple organ dysfunction syndrome
offer
offset
PaO2:FiO2pressure of arterial oxygen to fractional inspired oxygen concentration
pathologic
Patient
patients
patients with COVID-19
peer-reviewed
potential clinical benefits
pressure of arterial oxygen to fractional inspired oxygen concentration
prevent disease progression
Randomized
Randomized controlled trial
RCTrandomized controlled trial
reduce
reduce mortality
resulting
risk
role
Safe
SARS-CoV-2severe acute respiratory syndrome coronavirus 2
secondary hemophagocytic lymphohistiocytosis
selected
Sequential Organ Failure Assessment
severe acute respiratory syndrome coronavirus 2
sHLHsecondary hemophagocytic lymphohistiocytosis
SOFASequential Organ Failure Assessment
TAMOFthrombocytopenia-associated multiple organ failure
Therapeutic plasma exchange
thrombocytopenia-associated multiple organ failure
TNFTumor Necrosis Factor
TPE
TPEtherapeutic plasma exchange
treat
Treatment
tumor necrosis factor
while
with COVID-19
[DOI] 10.1016/j.transci.2022.103433 [Article Type] Review article
[DOI] 10.1016/j.transci.2022.103433 [Article Type] Review article
Reveal the Mechanisms of Yi-Fei-Jian-Pi-Tang on Covid-19 through Network Pharmacology Approach
네트워크 약리학 접근법을 통해 Covid-19에 대한 Yi-Fei-Jian-Pi-Tang의 메커니즘 공개
Article
[키워드] activated
activator
Adhesion Molecule
AKT
AKT1
Alpha
Beta
binding
C-C motif chemokine ligand
C-C motif chemokine ligand 2
cancers
CASP8
caspase
caspase 8
CCL2
chemokine
Chinese
contribute
Corona
Critical
CXCL8
Cytoscape
database
demonstrated
effective
EGFR
enhancer
enrichment analysis
epidermal
epidermal growth factor
ERBB2
Formula
foundation
Gene ontology
genomes
growth factor
Herb
HIF1a
HMOX1
hypoxia
ICAM1
IL10
IL1A
IL1B
IL2
IL4
IL6
ingredient
inhibitor
inquiry
intercellular
intercellular adhesion molecule
interferon gamma
interleukin
interleukin 2
Interleukin 4
interleukin 6
JUN
KEGG
Kyoto
Ligand
MAPK3
MAPK8
mechanism
Medicine
mitogen-activated protein kinase
MMP1
MMP3
motif
MPO
myeloperoxidase
Necrosis
network
network pharmacology
NFE2
NFE2L2
NFkB
NFKBIA
nitric oxide
nitric oxide synthase
NOS3
nuclear
oncogene
outcome
p53
pathway
Pathways
Patient
Pharmacology
PPARA
Protein
protein kinase
protein p53
protein-protein interaction
receptor
RELA
Research
Serine
Stat1
STRING database
subunit
target
target protein
targets
TCM
TGFB1
therapeutic target
threonine
Timp1
TNF
TP53
Traditional
Traditional Chinese medicine
Transcription
transcription factor
transforming growth factor
Tumor
tumor necrosis
tumor necrosis factor
tyrosine
UniProt
Virus Disease
[DOI] 10.1155/2022/1493137 PMC 바로가기 [Article Type] Article
[DOI] 10.1155/2022/1493137 PMC 바로가기 [Article Type] Article
Exploring the Immunomodulatory Aspect of Mesenchymal Stem Cells for Treatment of Severe Coronavirus Disease 19
중증 코로나바이러스 질환 치료를 위한 중간엽 줄기세포의 면역조절 측면 탐색 19
Review
[키워드] ACE-2
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
acute respiratory syndrome coronavirus-2
administration
affected
Alpha
alveolar epithelial cell
alveolar epithelial cells
angiotensin
angiotensin converting enzyme
angiotensin converting enzyme 2
anti-apoptotic
Anti-inflammatory
anti-oxidative
aspect
Asymptomatic
average
Betacoronavirus
breathlessness
cause
cellular
characterized
chemokines
chest pain
Clinical outcome
Clinical symptoms
colony-stimulating factor
coronavirus 2
COVID-19
COVID-19 patient
Critically ill
critically ill COVID-19 patients
curative
cytokine
Cytokine storm
Cytokine storms
damaged
dependent on
Deterioration
disease severity
dry cough
Effectiveness
Effects
elicited
endothelial
engage
enzyme
epithelial cells
excessive inflammation
family Coronaviridae
fatigue
Fever
fibroblast
fibroblast growth factor
functional
GCSF
genus
genus Betacoronavirus
granulocyte
granulocyte colony-stimulating factor
growth factor
Growth factors
Health
healthy
histological
IL-6
IL-7
IL-8
IL-9
immune cells
immune response
immune responses
immunomodulation
immunomodulatory
immunomodulatory capabilities
immunomodulatory capability
Incubation period
individual
infected individual
infected individuals
infiltrating immune cells
Inflammatory
Inflammatory cytokines
inflammatory protein
inhalation
Injury
Intention
interferon
interleukin
intravenous
intravenous infusion
Invasion
IP10
lung
Lungs
Macrophage
majority
MCP1
Mesenchymal stem cells
MIP1A
mitigate
monocyte
monocyte chemotactic protein-1
MSC
MSCs
multitude
myriad
Necrosis
organ
PDGFB
persistence
Platelet
platelet-derived growth factor
positioned
positive
Protein
receptor
reduce
respiratory
Respiratory droplets
RNA
SARS-CoV-2
SARS-COV-2 infection
secretion
Secretome
Severe acute respiratory syndrome
severe acute respiratory syndrome Coronavirus
severe acute respiratory syndrome coronavirus-2
sore throat
STEM
stem cell
stem cells
subunit
supportive therapy
symptomatic
therapeutic
therapy
tissue
TNF-α
translational
transmitted
Treatment
Tumor
tumor necrosis
tumor necrosis factor
tumor necrosis factor alpha
undergo
Vascular
virus
widespread
[DOI] 10.3390/cells11142175 PMC 바로가기 [Article Type] Review
[DOI] 10.3390/cells11142175 PMC 바로가기 [Article Type] Review
Contribution of CD4+ T cell-mediated inflammation to diarrhea in patients with COVID-19
COVID-19 환자의 설사에 대한 CD4+ T 세포 매개 염증의 기여
Article
Published on
Journal: International Journal of Infectious Diseases [Category] Coronavirus, COVID19(2023년), SARS, 바이오마커, 유전자 메커니즘, 치료기술,
Journal: International Journal of Infectious Diseases [Category] Coronavirus, COVID19(2023년), SARS, 바이오마커, 유전자 메커니즘, 치료기술,
[키워드] ACE2
analyzed
angiotensin
Angiotensin-converting enzyme
angiotensin-converting enzyme 2
association
CD4/CD8
CD4+
CD4+ T cell
CD4+ T cells
Cell
cells
chemokine
chemokines
Colon
contribute
correlation analyses
Correlation analysis
COVID-19
CXCL10
CXCL11
CXCR3
determine
diarrhea
distribution
expressed
expression
groups
Gut
identify
Inflammation
inflammation sites
lymphocyte
Lymphocyte subset
Lymphocyte subsets
mechanism
Migration
mRNA
mRNA expression
Necrosis
no difference
Patient
patients with COVID-19
percentage
percentages
performed
protease
protein levels
receptor
SARS-CoV-2
SARS-COV-2 infection
Serine
serine 2
significant difference
T cell
T cells
T-box
TNFα
transmembrane
transmembrane protease serine 2
Tumor
tumor necrosis
tumor necrosis factor
tumor necrosis factor-alpha
[DOI] 10.1016/j.ijid.2022.04.006 PMC 바로가기 [Article Type] Article
[DOI] 10.1016/j.ijid.2022.04.006 PMC 바로가기 [Article Type] Article